What are we going to do about AIDS and HTLV-III/LAV infection?

Nonviral interferon inducers.

The Journal of general physiology·2009

Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946).

AIDS research and human retroviruses·2001

Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients.

Journal of virology·2001

Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogs.

Antimicrobial agents and chemotherapy·2001

Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.

AIDS research and human retroviruses·2001

High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients.

Journal of clinical microbiology·2001

Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.

The New England journal of medicine·2026

Tozorakimab to Prevent COPD Exacerbations.

The New England journal of medicine·2026

Contemplative Pedagogy for Human-Centered Artificial Intelligence in Nursing Education.

The Journal of nursing education·2026

A comprehensive review of AI innovations for tackling antimicrobial resistance.

Le infezioni in medicina·2026

The interactive turn in generative AI for self-harm.

Frontiers in psychiatry·2026

Artificial intelligence in infection prevention and control education: toward intelligent, real-time clinical learning systems.

Frontiers in public health·2026

Instrumental succession: the gradual transfer of agency to AI.

Frontiers in psychology·2026

The representational bottleneck in rehabilitation AI: from human-cognitive proxies to pathway-based clinical representations.

Frontiers in digital health·2026

Related Experiment Videos

What are we going to do about AIDS and HTLV-III/LAV infection?

Related Concept Videos

Nonviral interferon inducers.

Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946).

Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients.

Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogs.

Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.

High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients.

Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.

Tozorakimab to Prevent COPD Exacerbations.

Contemplative Pedagogy for Human-Centered Artificial Intelligence in Nursing Education.

A comprehensive review of AI innovations for tackling antimicrobial resistance.

The interactive turn in generative AI for self-harm.

Artificial intelligence in infection prevention and control education: toward intelligent, real-time clinical learning systems.

Instrumental succession: the gradual transfer of agency to AI.

The representational bottleneck in rehabilitation AI: from human-cognitive proxies to pathway-based clinical representations.

Related Experiment Videos

What are we going to do about AIDS and HTLV-III/LAV infection?

Related Concept Videos

Related Articles